Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ornithine aminotransferase pseudogene (ENSG00000225055) is a DNA segment resembling the functional ornithine aminotransferase gene, but it is noncoding and nonfunctional. Pseudogenes, such as this, typically result from gene duplication or retrotransposition events. They lack the regulatory elements or coding integrity required to produce a functional protein and do not contribute to known cellular or clinical processes[3]. This pseudogene is catalogued for genome annotation purposes and used as a negative control or reference in some genomic analyses, but it is not a therapeutic target, biomarker, or drug interaction partner.
Not applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ornithine aminotransferase pseudogene (ENSG00000225055).